Grade My Investments

GSK plc (GSK) Stock Grade

GSK · Healthcare

A+
Grade updated: August 16, 2026
Computed by the GradeMyInvestments scoring model from revenue growth, profitability, balance-sheet strength, and analyst targets.
Market Cap
$99.2B
P/E Ratio
12.9
Revenue Growth (YoY)
+4.1%
Net Margin
17.5%
Return on Equity
35.0%
Dividend Yield
3.9%

About GSK plc's fundamentals

GSK is a large-cap pharmaceutical company with a market capitalization of $99.2 billion, trading at a P/E ratio of 12.9 which is relatively modest for the healthcare sector. The company demonstrated modest revenue growth of 4.1% year-over-year while maintaining a healthy net profit margin of 17.5%, indicating efficient cost management despite competitive industry pressures. GSK's return on equity stands at 35.0%, reflecting strong profitability relative to shareholder capital, and the company returns capital to investors through a 3.9% dividend yield.

Track GSK free — no credit card required. Live grade + monthly AI report →